BG62237B1 - Използване на5-тио-1,4-диазобицикло-[4,2,0]-октан-3,8-диоксосъединения приантитуморна терапия - Google Patents

Използване на5-тио-1,4-диазобицикло-[4,2,0]-октан-3,8-диоксосъединения приантитуморна терапия Download PDF

Info

Publication number
BG62237B1
BG62237B1 BG100020A BG10002095A BG62237B1 BG 62237 B1 BG62237 B1 BG 62237B1 BG 100020 A BG100020 A BG 100020A BG 10002095 A BG10002095 A BG 10002095A BG 62237 B1 BG62237 B1 BG 62237B1
Authority
BG
Bulgaria
Prior art keywords
compounds
diazobicyclo
thio
conh
hydrogen
Prior art date
Application number
BG100020A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100020A (bg
Inventor
Mice Kovacevic
Mira Grdisa
Kresimir Pavelic
Marjeta Horvatic
Zora Mandic
Mirjana Tomic
Jure J. Herak
Irena Lukic
Original Assignee
Pliva Farmaceutska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska filed Critical Pliva Farmaceutska
Publication of BG100020A publication Critical patent/BG100020A/bg
Publication of BG62237B1 publication Critical patent/BG62237B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG100020A 1994-09-21 1995-09-21 Използване на5-тио-1,4-диазобицикло-[4,2,0]-октан-3,8-диоксосъединения приантитуморна терапия BG62237B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR940577A HRP940577B1 (en) 1994-09-21 1994-09-21 Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy

Publications (2)

Publication Number Publication Date
BG100020A BG100020A (bg) 1996-04-30
BG62237B1 true BG62237B1 (bg) 1999-06-30

Family

ID=10946157

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100020A BG62237B1 (bg) 1994-09-21 1995-09-21 Използване на5-тио-1,4-диазобицикло-[4,2,0]-октан-3,8-диоксосъединения приантитуморна терапия

Country Status (14)

Country Link
EP (1) EP0705606B1 (de)
JP (1) JPH08310954A (de)
CN (1) CN1127115A (de)
AT (1) ATE164069T1 (de)
BG (1) BG62237B1 (de)
CA (1) CA2158678C (de)
CZ (1) CZ285621B6 (de)
DE (1) DE69501810T2 (de)
ES (1) ES2115303T3 (de)
HR (1) HRP940577B1 (de)
HU (1) HU218287B (de)
RU (1) RU2136284C1 (de)
SI (1) SI9500297A (de)
SK (1) SK280815B6 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598188A (en) * 1979-01-23 1980-07-25 Mitsui Toatsu Chem Inc Novel cephalosporin and its preparation
JPS57171994A (en) * 1981-04-15 1982-10-22 Asahi Chem Ind Co Ltd Novel compound
HRP921292A2 (en) 1992-11-17 1994-08-31 Pliva Pharm & Chem Works 5-thia-1,4-diazabicyclo (4.2.0.)octane -3,8-dioxo analogs of beta-lactams, the process for the preparation and use thereof

Also Published As

Publication number Publication date
SK117095A3 (en) 1996-09-04
SK280815B6 (sk) 2000-08-14
CZ285621B6 (cs) 1999-10-13
RU2136284C1 (ru) 1999-09-10
HRP940577A2 (en) 1997-04-30
DE69501810D1 (de) 1998-04-23
ATE164069T1 (de) 1998-04-15
CN1127115A (zh) 1996-07-24
EP0705606A1 (de) 1996-04-10
HRP940577B1 (en) 1998-12-31
SI9500297A (en) 1996-04-30
BG100020A (bg) 1996-04-30
HU9502770D0 (en) 1995-11-28
CZ244795A3 (en) 1996-04-17
DE69501810T2 (de) 1998-09-24
EP0705606B1 (de) 1998-03-18
CA2158678C (en) 2000-04-18
CA2158678A1 (en) 1996-03-22
HU218287B (en) 2000-07-28
JPH08310954A (ja) 1996-11-26
ES2115303T3 (es) 1998-06-16
HUT74422A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
DE69516141T2 (de) Enzymhemmer
DE3881489T2 (de) Peptide mit collagenase hemmender wirkung.
WO2012034116A2 (en) Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
DE4418097A1 (de) Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
WO2013052263A2 (en) Antifungal compounds
US3991190A (en) Treatment of viral infections
US5190937A (en) Lactam derivatives
GB2158440A (en) 4,5,6,7-Tetrahydroimidazo[4,5-c]pyridine derivatives
RU2268889C2 (ru) Применение производных цистеина для получения лекарственного средства, предназначенного для лечения патологий, возникающих вследствие образования гетеротримерного протеина g
EP4043467A1 (de) Klasse von funktionellen molekülen, die auf proteolysewege abzielen, herstellung und verwendung davon
PL346547A1 (en) Unsaturated hydroximic acid derivatives as parp inhibitors
BG62237B1 (bg) Използване на5-тио-1,4-диазобицикло-[4,2,0]-октан-3,8-диоксосъединения приантитуморна терапия
WO2013040526A1 (en) Antimicrobial compounds
DE102005009784A1 (de) Peptid-Mimetika und ihre Verwendung als Inhibitoren des 20S Proteasoms, 26S Proteasoms und Immunoproteasoms
SU820658A3 (ru) Способ получени производных1-фЕНилэТАНОлАМиНА или иХ СОлЕй
CN114097807B (zh) 巴多索隆类化合物在抗农业病原真菌中的用途
CN111116647B (zh) 一种具有hdac抑制活性的磷酸类化合物及其制备方法与用途
EP0299413B1 (de) Tetramethyl-cis-diaza-bicyclo[4.2.0.]oktan-3,5-dion-Derivate mit differentiationsinduzierender Aktivität
Feher et al. Effect of Amino-Acid Esters on the Growth of Fibroblast Cultures
TW442483B (en) Antineoplastic pyrimidine Α-methylene-γ-butyrolactones
SU1055105A1 (ru) Гидрохлорид 4-адамантоиламино-3-0-адамантоил-6-метил-2-этил-пиридин, обладающий психостимулирующей активностью, повышающий физическую работоспособность и имеющий антикаталептическую активность
CN110256416A (zh) 组蛋白去乙酰化酶抑制剂及其制备方法与用途
CN109928923A (zh) 一类作为ido抑制剂化合物
SE435275B (sv) Analogiforfarande for framstellning av nya ettiksyraderivat
CN109928919A (zh) 作为ido抑制剂的环己烷类化合物